Return to Listing

2 result(s) for LGX818

PI Name Protocol # Title
Matthew Taylor IRB00009397 A Phase Ib/II, Multicenter Study of LEE011 in Combination with LGX818 in Adult Patients with BRAF Mutant Melanoma
Matthew Taylor IRB00010427 [Quroum] Modular Phase II Study to Link Targeted Therapy to Patients with Pathway Activated Tumors: Module 4 - LGX818 for Patients with BRAFV600E Mutated Tumors
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080

You may qualify for additional trials within our Phase 1 Program